The St. George's Respiratory Questionnaire Appendix to the Food and Drug Administration Draft Guidance on COPD: Why a Small Step Forward Is So Important

Chest. 2017 Nov;152(5):914-916. doi: 10.1016/j.chest.2017.07.040.

Authors

Stephen I Rennard¹, Debora Merrill², Ruth Tal-Singer³, Frank C Sciurba⁴

Affiliations

¹ Larson Professor of Respiratory Research, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE; Clinical Discovery Unit, AstraZeneca, Melbourn, England. Electronic address: srennard@unmc.edu.
² COPD Biomarker Qualification Consortium, COPD Foundation, Washington, DC.
³ GSK R&D, King of Prussia, PA.
⁴ Division of Pulmonary Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA.

PMID: 29126533
DOI: 10.1016/j.chest.2017.07.040

No abstract available

Publication types

Editorial

MeSH terms

Biomarkers / analysis
Drug Development / methods*
Humans
Outcome Assessment, Health Care / methods*
Pulmonary Disease, Chronic Obstructive / diagnosis
Pulmonary Disease, Chronic Obstructive / drug therapy*
Surveys and Questionnaires
United States
United States Food and Drug Administration

Substances

Biomarkers